Breen Michael Martin 4
4 · GT Biopharma, Inc. · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Breen Michael Martin
Director
Transactions
- Award
Option to purchase Common Stock
2025-09-04+100,000→ 100,000 totalExercise: $1.33Exp: 2035-08-19→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The options are fully vested and exercisable.
- [F2]The option vests in four equal quarterly installments beginning on January 1, 2025.
- [F3]The option vests in four equal quarterly installments beginning on January 1, 2026.